CD40LG and infection: LFIA has already been used for SARS-CoV-2 IgG/IgM prevalence studies worldwide [25] and, considering that IgM and IgG tests have different sensitivity in relation to the phases of the infection (e.g., IgM antibodies increase earlier than IgG) [9], we have combined IgG and IgM testing to improve sensitivity [10].